{"id":"W4409518994","doi":"10.1111/ene.70158","title":"Long‐Term Efficacy and Safety of Ravulizumab in Adults With Anti‐Acetylcholine Receptor Antibody‐Positive Generalized Myasthenia Gravis: Final Results From the Phase 3 CHAMPION MG Open‐Label Extension","year":2025,"lang":"en","type":"article","venue":"European Journal of Neurology","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; University of Toronto; London Health Sciences Centre","funders":"Alexion Pharmaceuticals; AstraZeneca","keywords":"Myasthenia gravis; Medicine; Placebo; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001200737,0.0002840457,0.0008441582,0.0002425564,0.0001164344,0.00003524357,0.0004268595,0.00006694101,0.00002718642],"category_scores_gemma":[0.0003558867,0.0001593023,0.00007882874,0.0003501622,0.0002680255,0.000114653,0.0002272338,0.0007533327,0.000004625741],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001663319,"about_ca_system_score_gemma":0.0001178684,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004771071,"about_ca_topic_score_gemma":0.00001799137,"domain_scores_codex":[0.9963951,0.001417013,0.001180797,0.0004527481,0.0002617741,0.0002925495],"domain_scores_gemma":[0.9978933,0.0003529508,0.0008152082,0.000465187,0.0003273966,0.0001459852],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6445683,0.003775412,0.01948903,0.00009916974,0.0005258525,0.008864845,0.004608826,0.00005491921,0.2213625,0.0001797081,0.001985682,0.0944858],"study_design_scores_gemma":[0.1450381,0.01112657,0.8354777,0.002142377,0.0002253748,0.001555968,0.00005884122,0.0001685382,0.001487338,0.00001956598,0.002515082,0.0001844778],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9884769,0.0008174757,0.0003784288,0.009086969,0.0002492511,0.0006096213,0.00008559554,0.000009462189,0.0002862393],"genre_scores_gemma":[0.9960223,0.00107515,0.0007213772,0.001726777,0.0002111653,9.244667e-7,0.0001086781,0.00003991872,0.00009373195],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8159887,"threshold_uncertainty_score":0.6496159,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0267167186454999,"score_gpt":0.318157775286445,"score_spread":0.2914410566409451,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}